CCL4 and melanoma: Immunohistochemical analyses and database studies have shown that higher CCL4 levels correlate with improved survival in primary melanoma patients [235], while T-cell single-cell RNA sequencing in metastatic melanoma patients suggests its association with durable responses to ICB [236].